ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes
- 18 August 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (14), 1474-1486
- https://doi.org/10.1002/pros.20477
Abstract
Co-factor ACTR is frequently overexpressed and/or amplified in multiple types of tumors. The mechanism of its function in prostate cancer (CaP) is still unclear. The effects of ACTR and androgen receptor (AR) depletion on cell proliferation and gene expression and their functions were analyzed in a panel of androgen-dependent and -independent CaP cells and CWR22 xenograft. ACTR and AR, but not TIF2, are required for proliferation of androgen-dependent and -independent cells, and for tumor growth. While AR depletion inhibited the expression of cyclin D1, cyclin B, and cdc2, ACTR depletion reduced the expression of cyclin E and cdk2. In response to serum stimulation, AR and ACTR are recruited to the corresponding target gene promoters to activate their expression in androgen-independent manner. These findings suggest that AR and ACTR may play important roles in androgen ablation resistance by controlling key cell cycle gene expression.Keywords
Funding Information
- NIH (DK60019, DOD DAMD17-01-1-0033)
- UC Davis Health System
This publication has 50 references indexed in Scilit:
- Regulation of androgen receptor signaling in prostate cancerExpert Review of Anticancer Therapy, 2005
- Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancerEndocrine-Related Cancer, 2004
- Androgen deprivation therapy for prostate cancer: Current status and future prospectsThe Prostate, 2004
- Androgen Receptor in Prostate CancerEndocrine Reviews, 2004
- Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotypeJournal of Cellular Biochemistry, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003
- Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancerBritish Journal of Cancer, 2001
- Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion KinaseMolecular and Cellular Biology, 2001
- The development of androgen-independent prostate cancerNature Reviews Cancer, 2001